Business leaders hope lawmakers will address health issues they say are burdening businesses in the state.

Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.

New research shows the number of kids who qualify as obese in Central Indiana increased during the COVID-19 pandemic, with around 36% increase in obesity among young people ages 2-19.

More than three fourths of Americans lose sleep because of digital distractions, according to a new survey from the American Academy of Sleep Medicine.

A new state report shows that overdoses fell five percent in 2022, for the first time since 2018. State officials tout expanded access to harm reduction and treatment resources as a reason behind the trend.

Indianapolis-based Community Health Network has agreed to pay the United States $345 million in a settlement after accusations of submitting false claims to Medicare.

Language and financial barriers present a challenge for Hoosiers trying to keep up-to-date on their vaccine schedules, or even starting them. An Indiana immunization group is using new grant funding to expand its services for additional languages.

The state is delaying the return of Medicaid premiums and expects to release its plan to restart POWER accounts in January. Some Indiana Medicaid advocates are still hoping the federal agency in charge of Medicaid will prevent the resumption of premiums before then.

The court's action sets up a collision between the Food and Drug Administration's 23-year study and supervision of mifepristone, and the circumstances under which it can be prescribed.

The FDA just approved new gene therapies for sickle cell disease. Now, ensuring access to the treatment is top of mind for patients and doctors.